Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
Go back to Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule| (NASDAQ: LEXX) | Delayed: 10.80 +0.48 (4.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.32 | 52 Week High | $ | |||
| Open | $10.18 | 52 Week Low | $ | |||
| Day High | $11.01 | P/E | N/A | |||
| Day Low | $10.18 | EPS | $ | |||
| Volume | 5,795 | |||||
